La Jolla Pharmaceutical Company – NASDAQ:LJPC
La Jolla Pharmaceutical Company stock price today
La Jolla Pharmaceutical Company stock price monthly change
La Jolla Pharmaceutical Company stock price quarterly change
La Jolla Pharmaceutical Company stock price yearly change
La Jolla Pharmaceutical Company key metrics
Market Cap | N/A |
Enterprise value | 108.77M |
P/E | 47.61 |
EV/Sales | 2.33 |
EV/EBITDA | 6.90 |
Price/Sales | 3.37 |
Price/Book | -2.25 |
PEG ratio | 0.31 |
EPS | 0.04 |
Revenue | 46.49M |
EBITDA | 15.76M |
Income | 1.52M |
Revenue Q/Q | -34.34% |
Revenue Y/Y | -33.78% |
Profit margin | 8.54% |
Oper. margin | -5.53% |
Gross margin | 80.94% |
EBIT margin | -5.53% |
EBITDA margin | 33.9% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLa Jolla Pharmaceutical Company stock price history
La Jolla Pharmaceutical Company stock forecast
La Jolla Pharmaceutical Company financial statements
| Sep 2021 | 13.31M | -2.26M | -16.97% |
|---|---|---|---|
| Dec 2021 | 12.21M | 1.32M | 10.82% |
| Mar 2022 | 10.42M | 2K | 0.02% |
| Jun 2022 | 10.54M | 2.45M | 23.31% |
| 2021-11-04 | -0.07 | -0.08 |
|---|---|---|
| 2022-03-09 | 0.04 | 0.12 |
| 2022-05-16 | 0.01 | -0.15 |
| Sep 2021 | 100294000 | 168.70M | 168.21% |
|---|---|---|---|
| Dec 2021 | 101230000 | 167.96M | 165.93% |
| Mar 2022 | 96378000 | 166.87M | 173.14% |
| Jun 2022 | 99366000 | 168.83M | 169.91% |
| Sep 2021 | 766K | -9K | 120K |
|---|---|---|---|
| Dec 2021 | 3.16M | -9K | -3.26M |
| Mar 2022 | 2.52M | 0 | -5.02M |
| Jun 2022 | 6.68M | 271K | -2.78M |
La Jolla Pharmaceutical Company alternative data
| Aug 2023 | 61 |
|---|---|
| Sep 2023 | 61 |
| Oct 2023 | 61 |
| Nov 2023 | 61 |
| Dec 2023 | 61 |
| Jan 2024 | 61 |
| Feb 2024 | 61 |
| Mar 2024 | 61 |
| Apr 2024 | 61 |
| May 2024 | 61 |
| Jun 2024 | 61 |
| Jul 2024 | 61 |
La Jolla Pharmaceutical Company other data
| Period | Buy | Sel |
|---|---|---|
| May 2021 | 752021 | 0 |
| Jun 2021 | 59092 | 0 |
| Nov 2021 | 7500 | 263745 |
| Dec 2021 | 24500 | 177545 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | JOHNSON CRAIG A director | Employee Stock Option (Right to Buy) | 12,000 | $3.93 | $47,160 | ||
Option | JOHNSON CRAIG A director | Common Stock | 12,000 | $3.93 | $47,160 | ||
Purchase | RAMSAY DAVID A director | Common Stock | 10,000 | $3.81 | $38,090 | ||
Purchase | RAMSAY DAVID A director | Common Stock | 4,399 | $3.66 | $16,100 | ||
Purchase | RAMSAY DAVID A director | Common Stock | 10,101 | $3.74 | $37,737 | ||
Sale | TANG KEVIN C director, 10 perc.. | Common Stock | 177,545 | $3.71 | $659,047 | ||
Sale | TANG KEVIN C director, 10 perc.. | Common Stock | 70,342 | $3.95 | $277,781 | ||
Sale | TANG KEVIN C director, 10 perc.. | Common Stock | 193,403 | $4.1 | $793,146 | ||
Purchase | RAMSAY DAVID A director | Common Stock | 7,500 | $4.23 | $31,725 | ||
Purchase | TANG KEVIN C director, 10 perc.. | Common Stock | 59,092 | N/A | N/A |
| Patent |
|---|
Application Filling date: 30 Jul 2021 Issue date: 23 Jun 2022 |
Application Filling date: 19 Dec 2017 Issue date: 6 May 2021 |
Application Filling date: 18 Jan 2018 Issue date: 7 Nov 2019 |
Application Filling date: 22 Feb 2019 Issue date: 17 Oct 2019 |
Application Filling date: 21 Mar 2019 Issue date: 8 Aug 2019 |
| Quarter | Transcript |
|---|---|
| Q4 2018 5 Mar 2019 | Q4 2018 Earnings Call Transcript |
| Q3 2018 25 Oct 2018 | Q3 2018 Earnings Call Transcript |
| Q2 2018 9 Aug 2018 | Q2 2018 Earnings Call Transcript |
Monday, 22 August 2022 | ||
| Innoviva Completes Acquisition of La Jolla Pharmaceutical | businesswire.com | |
Tuesday, 12 July 2022 | ||
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating La Jolla Pharmaceuticals Company Buyout | newsfilecorp.com | |
Monday, 11 July 2022 | ||
| SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company | prnewswire.com | |
| La Jolla Pharmaceutical Company (LJPC) Stock: Why It Skyrocketed Over 80% Today | Pulse2 |
-
What's the price of La Jolla Pharmaceutical Company stock today?
One share of La Jolla Pharmaceutical Company stock can currently be purchased for approximately $6.22.
-
When is La Jolla Pharmaceutical Company's next earnings date?
Unfortunately, La Jolla Pharmaceutical Company's (LJPC) next earnings date is currently unknown.
-
Does La Jolla Pharmaceutical Company pay dividends?
No, La Jolla Pharmaceutical Company does not pay dividends.
-
What is La Jolla Pharmaceutical Company's stock symbol?
La Jolla Pharmaceutical Company is traded on the NASDAQ under the ticker symbol "LJPC".
-
What is La Jolla Pharmaceutical Company's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of La Jolla Pharmaceutical Company?
Shares of La Jolla Pharmaceutical Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are La Jolla Pharmaceutical Company's key executives?
La Jolla Pharmaceutical Company's management team includes the following people:
- Mr. Larry G. Edwards Pres, Chief Executive Officer & Director(age: 53, pay: $749,170)
- Dr. Lakhmir S. Chawla Consultant(age: 54, pay: $478,970)
- Mr. Michael S. Hearne Chief Financial Officer & Sec.(age: 62, pay: $186,040)
-
How many employees does La Jolla Pharmaceutical Company have?
As Jul 2024, La Jolla Pharmaceutical Company employs 61 workers.
-
When La Jolla Pharmaceutical Company went public?
La Jolla Pharmaceutical Company is publicly traded company for more then 31 years since IPO on 3 Jun 1994.
-
What is La Jolla Pharmaceutical Company's official website?
The official website for La Jolla Pharmaceutical Company is lajollapharmaceutical.com.
-
Where are La Jolla Pharmaceutical Company's headquarters?
La Jolla Pharmaceutical Company is headquartered at 4550 Towne Centre Ct, San Diego, CALIFORNIA.
-
How can i contact La Jolla Pharmaceutical Company?
La Jolla Pharmaceutical Company's mailing address is 4550 Towne Centre Ct, San Diego, CALIFORNIA and company can be reached via phone at +1 858 207 4264.
La Jolla Pharmaceutical Company company profile:
La Jolla Pharmaceutical Company
lajollapharmaceutical.comNASDAQ
61
Biotechnology
Healthcare
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.
San Diego, CALIFORNIA 02451
CIK: 0000920465
ISIN: US5034596040
CUSIP: 503459604
